Warriner AH - Search Results

1

An Internet-based Controlled Trial Aimed to Improve Osteoporosis Prevention among Chronic Glucocorticoid Users.

Warriner AH, Outman RC, Allison JJ, Curtis JR, Markward NJ, Redden DT, Safford MM, Stanek EJ, Steinkellner AR, Saag KG. Warriner AH, et al. J Rheumatol. 2015 Aug;42(8):1478-83. doi: 10.3899/jrheum.141238. Epub 2015 Jul 1. J Rheumatol. 2015. PMID: 26136484 Clinical Trial.

2

Adherence to osteoporosis treatments: room for improvement.

Warriner AH, Curtis JR. Warriner AH, et al. Curr Opin Rheumatol. 2009 Jul;21(4):356-62. doi: 10.1097/BOR.0b013e32832c6aa4. Curr Opin Rheumatol. 2009. PMID: 19412103 Free PMC article. Review.

3

Osteoporosis diagnosis and medical treatment.

Warriner AH, Saag KG. Warriner AH, et al. Orthop Clin North Am. 2013 Apr;44(2):125-35. doi: 10.1016/j.ocl.2013.01.005. Epub 2013 Feb 26. Orthop Clin North Am. 2013. PMID: 23544819 Review.

4

Study design considerations for a large simple trial of bisphosphonates.

Wright NC, Warriner AH, Saag KG. Wright NC, et al. Among authors: warriner ah. Curr Opin Rheumatol. 2013 Jul;25(4):517-23. doi: 10.1097/BOR.0b013e328362062b. Curr Opin Rheumatol. 2013. PMID: 23656714 Review.

5

Prevention and treatment of bone changes associated with exposure to glucocorticoids.

Warriner AH, Saag KG. Warriner AH, et al. Curr Osteoporos Rep. 2013 Dec;11(4):341-7. doi: 10.1007/s11914-013-0173-0. Curr Osteoporos Rep. 2013. PMID: 24097304 Free PMC article. Review.

6

Glucocorticoid-related bone changes from endogenous or exogenous glucocorticoids.

Warriner AH, Saag KG. Warriner AH, et al. Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):510-6. doi: 10.1097/01.med.0000436249.84273.7b. Curr Opin Endocrinol Diabetes Obes. 2013. PMID: 24468753 Review.

7

Effect of self-referral on bone mineral density testing and osteoporosis treatment.

Warriner AH, Outman RC, Feldstein AC, Roblin DW, Allison JJ, Curtis JR, Redden DT, Rix MM, Robinson BE, Rosales AG, Safford MM, Saag KG. Warriner AH, et al. Med Care. 2014 Aug;52(8):743-50. doi: 10.1097/MLR.0000000000000170. Med Care. 2014. PMID: 24984211 Free PMC article. Clinical Trial.

8

Improving quality of care in osteoporosis: opportunities and challenges.

Teng GG, Warriner A, Curtis JR, Saag KG. Teng GG, et al. Curr Rheumatol Rep. 2008 Apr;10(2):123-30. doi: 10.1007/s11926-008-0022-9. Curr Rheumatol Rep. 2008. PMID: 18460267 Review.

9

Challenges in defining quality of care for glucocorticoid-induced osteoporosis: defending good against perfect.

Saag KG, Curtis J, Warriner A. Saag KG, et al. J Rheumatol. 2013 Oct;40(10):1640-2. doi: 10.3899/jrheum.130980. J Rheumatol. 2013. PMID: 24085752 No abstract available.

10

Assessing the feasibility of the Effectiveness of Discontinuing Bisphosphonates trial: a pilot study.

Wright NC, Foster PJ, Mudano AS, Melnick JA, Lewiecki EM, Shergy WJ, Curtis JR, Cutter GR, Danila MI, Kilgore ML, Lewis EC, Morgan SL, Redden DT, Warriner AH, Saag KG. Wright NC, et al. Among authors: warriner ah. Osteoporos Int. 2017 Aug;28(8):2495-2503. doi: 10.1007/s00198-017-4073-5. Epub 2017 May 24. Osteoporos Int. 2017. PMID: 28540506 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page